Revenue: As of FY2025, the actual value is USD 0.EPS: As of FY2025, the actual value is USD -0.02.EBIT: As of FY2025, the actual value is USD -768.24 K.<h3>Operational Metrics</h3><ul><li>Net Loss: The net loss for the fiscal year ended July 31, 2025, was - $1,742,691, compared to - $842,316 for the fiscal year ended July 31, 2024, representing an increase in net loss by 107%.</li><li>General and Administrative Expense: General and administrative expenses decreased by 51% from $2,084,446 in 2024 to $1,020,753 in 2025.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: Net cash used in operating activities was - $347,392 for the fiscal year ended July 31, 2025, compared to - $1,215,210 for the fiscal year ended July 31, 2024.</li><li>Net Cash Provided by Investing Activities: Net cash provided by investing activities was $69,787 for the fiscal year ended July 31, 2025, compared to $1,000,000 for the fiscal year ended July 31, 2024.</li><li>Net Cash Provided by Financing Activities: Net cash provided by financing activities was $294,310 for the fiscal year ended July 31, 2025, compared to $180,724 for the fiscal year ended July 31, 2024.</li></ul><h3>Debt</h3><ul><li>Convertible Note with LGH Investments, LLC: As of July 31, 2025, the principal amount outstanding was $1,035,000 with accrued interest of $256,676.</li><li>Mast Hill Convertible Promissory Note: As of July 31, 2025, the principal amount outstanding was $499,667 with accrued interest of $76,661.</li></ul><h3>Outlook / Guidance</h3><ul><li>The company is focused on raising additional capital to meet its obligations and continue operations. It plans to obtain capital through debt or equity issuances or collaborative arrangements with corporate partners.</li></ul>

Odyssey Health, Inc. | 10-K: FY2025 Revenue: USD 0